First CRISPR-Cas9 Clinical Trial to be Sponsored by a U.S. Company Commences
Scientists in China have already conducted clinical trials of CRISPR-Cas9 gene editing technology on humans, but the technology has yet to be green-lighted in the United States. While CRISPR-Cas9 has…








